Non-Executive Director

Jan Groen is currently the CEO of Novigenix SA in Switzerland and holds a PhD in medical microbiology from the Erasmus University in Rotterdam. He has many years of management experience (VP R&D, COO, CEO) in the life science industry with a focus on emerging technologies, product development and commercialization. Jan has raised over $150…

Non-Executive Director

Todd holds a BSc in Bioengineering and Pre-Medicine from The Catholic University of America (Washington, USA). Todd is a highly successful international healthcare executive with more than 30+ years’ experience in life sciences companies. He has worked as global sales director for companies in molecular diagnostics, laboratory services, and medical devices such as Interleukin Genetics,…

Non-Executive Director

Jorge holds a Master’s Degree in Industrial Production from ICADE (Madrid, Spain) and a MBA from Instituto de Empresa (Madrid, Spain). He joined the family business Laboratorios Landerlan in 1980, responsible for blood derivatives production. In 1988, he became a Director of Landerland Diagnostico, a position he held until 1999. From 1999 to 2017, he…

Co-Founder and Executive Director

Juan J. Diaz Mochón became CEO of DESTINA following the unexpected passing of Hugh Ilyine, founder and previous CEO of DESTINA. Juan worked with Hugh for more than 10 years as CSO of DESTINA. They worked in a true partnership with Juan managing all the scientific, research and technological activities of the company. He was…

Executive Chairman

David Whitcombe has more than 10 years of academic research and 15 years in industrial R&D. David has produced a number of publications and patents including the Scorpions technology that formed the basis of his start-up business DxS Ltd in 2000. He was Head of Technology Development at AstraZeneca Diagnostics for four years leading a…